IRCT20160422027520N19招募中1 期
Intradermal lymphocyte therapy in recurrent pregnancy loss patients with immunologic abnormalities
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 40 years（—）
- 性别
- All
入选标准
- •Having at least three consecutive abortions
- •Having regular menstrual cycles
- •BMI of people below 30
- •Have no uterine pathology
- •Our patients will be selected only from Azerbaijan.
- •Patients were selected whose semen analysis and DNA fragmentation test were normal.
排除标准
- •Patients under the age of 18 and over 40 years
- •Patients who themselves or their spouse have abnormal karyotypes or genetic or chromosomal abnormalities.
- •Patients with chronic underlying disease who have to take certain medications.
- •Patients with intrauterine anomalies.
- •Having polycystic ovary syndrome
- •Patients who test positive for HIV, HCV or HBV
研究者
相似试验
尚未招募
不适用
Epicutaneous and / or intralymphatic immunotherapy for nasal allergyJapanese cedar pollinosisJPRN-UMIN000015278Osaka Medical College Otorhinolaryngology36
进行中（未招募）
1 期
Pollenvaccination in humans, via a lymph node, with doses up to 10 000SQ-U. .Patients with severe to moderate Allegic rhinitis.EUCTR2015-001259-63-SEDepartment of Clinical Science, Intervention and Technology, Karolinska Institute80
终止
3 期
Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)InfertilityNCT01916798Cairo University200
招募中
不适用
Intravenous immunoglobulin or intralipid treatment for recurrent pregnancy loss or implantation failures women with NK cell abnormalityRecurrent pregnancy loss, implantation failureJPRN-UMIN000038952Hyogo College of Medicine100
已完成
不适用
Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent MiscarriageMiscarriage, RecurrentAbortion, HabitualNCT00606905University of Chicago82